Plasminogen activators in breast-cancer cells

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Plasminogen activators (PAs) play critical roles in cancer progression.
• Urokinase-type PA (u-PA) and tissue-type PA (t-PA) exhibit distinct functions in breast cancer.
• Estrogen receptor signaling influences t-PA production.

Purpose of the Study:

• To review experimental and clinical studies on PA expression in breast cancer.
• To elucidate the differential roles of u-PA and t-PA in breast cancer.
• To evaluate PAs as potential prognostic markers.

Main Methods:

• Review of experimental and clinical studies.
• Analysis of PA expression patterns.
• Correlation of PA levels with patient survival and metastasis.

Main Results:

• High u-PA levels correlate with poor disease-free and overall survival, indicating its role as a prognostic marker for breast cancer.
• t-PA production is estrogen-regulated, suggesting its utility as a marker for estrogen action.
• While generally associated with a good prognosis, t-PA may contribute to bone-only metastasis.

Conclusions:

• u-PA is a significant negative prognostic marker in breast cancer, linked to invasion and metastasis.
• t-PA serves as a marker for estrogen action and is generally associated with favorable outcomes, despite a role in bone metastasis.